Pain：针灸可有效预防癫痫复发和加重

记者从日前在京召开的2011年医家国际间研讨会上获悉，首都医科大学附属北京中医医院医家外围经病理深入研究表明，传统的中医医家疗法可有效持续性癫痫的病情恶化和加重。具体深入研究期刊近日刊载在国际间都曾Review《瘙痒》上，成为中国大陆首篇刊载于该杂志的病理深入研究期刊。该文还被国际间知名现代医学免疫学独立机构 Faculty of 1000 medicine（千名现代医学家）附送。

据洞察，作为病理常见病之一，癫痫死亡率高，且危害严重。目前，要务18岁~65岁人群的癫痫患病率高达9.3%，且有骤然增高趋向。医家外科手术痉挛在中国仍未有数千年的历史。北京中医医院医家外围自2004年设立痉挛专家门诊，积极参与了基于“马鞍王乐亭”、国医大师贺普仁等多位都曾医家学家治痛经验的痉挛深入研究。

据该外围所长王麟鹏解说，该项目实行单盲、双模拟、结果显示的表达方式，在国内5家医院的医家科总共招募140名无后遗症癫痫患者，随机分为两第三组，则有外科手术第三组（医家加安慰剂）和准确率（假针加氟桂利嗪）。两第三组患者每周医家外科手术3次，每晚口服药物。结果显示，4周后，外科手术第三组癫痫的有效纾缓率为59%，准确率为40%；外科手术第三组瘙痒天数少于减少4.1天，准确率少于减少1.9天。16周后，外科手术第三组有效纾缓率为56%，准确率为37%；外科手术第三组瘙痒天数少于减少 4.1天，准确率少于减少2天。

深入研究执法人员据此认为，医家可以作为癫痫的持续性病情恶化和加重的方法，其治果也优于此前境外的具体深入研究。由于其深入研究方法的独创和重要性，该期刊还被国际间知名现代医学免疫学独立机构“千名科学家”附送。（生物谷 Bioon.com）

doi:10.1016/j.pain.2011.04.006PMC:PMID:

Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial

Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li

Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were ailable to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual ogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.